Nagashima, K., Kikuchi, S., Iyama, S., Fujita, C., Goto, A., Horiguchi, H., & Kobune, M. (2020). Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission. Clin Case Rep.

Nagashima, Kana, Shohei Kikuchi, Satoshi Iyama, Chisa Fujita, Akari Goto, Hiroto Horiguchi, and Masayoshi Kobune. "Successful Brentuximab Vedotin Monotherapy against Late Relapse of Classical Hodgkin Lymphoma 6 years After First Remission." Clin Case Rep 2020.

Nagashima, Kana, et al. "Successful Brentuximab Vedotin Monotherapy against Late Relapse of Classical Hodgkin Lymphoma 6 years After First Remission." Clin Case Rep 2020.